The Ross Eye Institute conducts cutting-edge clinical trials in the field of ophthalmology, aiming to advance our understanding of eye diseases while offering patients access to groundbreaking treatments and therapies for a wide range of eye conditions. Through rigorous research and collaboration with leading experts, the institute strives to translate scientific advancements into tangible improvements in eye health and patient vision outcomes.
A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
Enrolling children from birth through age 3 with non-acquired/congenital cataracts
Learn More: https://clinicaltrials.gov/ct2/show/NCT05191706
Baerveldt 350mm vs. Clear Path 250 mm: recruiting for this study comparing two glaucoma drainage devices.
DECLARE- Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE), seeking enrollment of 25 patients
Learn More: https://clinicaltrials.gov/ct2/show/NCT04542616
A prospective, randomized, multi-center evaluation of the Safety and Effectiveness of the STREAMLINE®SURGICAL SYSTEM compared to iStent Inject W® in Patients with Open-Angle Glaucoma: seeking enrollment of patients with mild-moderate glaucoma undergoing cataract surgery
Learn More: https://clinicaltrials.gov/ct2/show/NCT05280366
The quick contact form found in the footer of all pages.
1176 Main St.
Buffalo, NY 14209
3580 Sheridan Drive
Amherst, NY 14226